Searchable abstracts of presentations at key conferences in endocrinology

ea0059oc4.6 | Clinical highlights | SFEBES2018

11C-Methionine PET/MRI is superior to MRI for localisation of functioning prolactinomas and may facilitate targeted intervention

Bashari Waiel , Powlson Andrew , Senanayake Russell , Sekaran Arvindh , Serban Laura , Koulouri Olympia , Gillet Daniel , Cheow Heok , Mendichovszky Iosif , Gurnell Mark

Background: Prolactinomas are the commonest hormone-secreting pituitary adenomas. First-line treatment is dopamine agonist (DA) therapy. However, side-effects are increasingly recognised, leading to an increasing consideration of transsphenoidal surgery (TSS) and/or radiotherapy. Co-registration of 11C-methionine Positron Emission Tomography (Met-PET) imaging with Spoiled Gradient Recalled Acquisition MRI (SPGR MRI), referred to in combination as Met-PET/MRI, can aid accurate ...